Mount a Defense Against Equine Influenza
Vaccinations can help protect horse health heading into fall shows.
September 10, 2014
From AQHA Corporate Partner Zoetis
Traveling to events can put horse health to the test. Maybe it’s a trip to a training session or a big show like the upcoming All American Quarter Horse Congress. Unfortunately, this can be the time of year when upper respiratory disease, such as equine influenza, is all too common.
Whenever you expose your horse to other horses, you pose a risk to his health. But there are things you can do to help protect your horse from disease — most importantly, vaccination.
Without vaccination against equine influenza virus (EIV), horse owners can face a financial risk of up to $885, based on diagnostics, treatment and days of missed training.*
The Equine Influenza Calculator app compares the cost of vaccination with the cost to treat for disease and training days lost. Using the calculator, a horse owner or veterinarian can determine equine influenza risk depending on the horse’s vaccination status and help create an effective vaccination program. The Equine Influenza Calculator app is available for free in the Apple® App Store®.
Interested in learning more about other health problems that can affect your horse? Download AQHA’s FREE Potomac Horse Fever report.
Consider vaccination with the FLUVAC INNOVATOR® line of vaccines to help provide protection against EIV. Through a partnership with the Gluck Equine Research Center at the University of Kentucky, Zoetis continues its legacy of evaluating the FLUVAC INNOVATOR line of vaccines to help ensure the most relevant protection.4-8 In fact, the FLUVAC INNOVATOR line of vaccines set the standard for equine influenza vaccines with test studies against six EIV strains since 2002.4-8
Most recently, a serologic response study demonstrated an immune response with the FLUVAC INNOVATOR vaccine line against Richmond 07.8 Even though Richmond 07 is not circulating in the United States, it might be a threat to horses with international exposure; therefore Zoetis tested it against the FLUVAC INNOVATOR vaccine line, which demonstrated that it was effective in stimulating a cross-reactive immune response.
That’s why horse owners can depend on the FLUVAC INNOVATOR line of vaccines, which helps offer protection against circulating EIV strains, and know that Zoetis will continue to test and evaluate it.
The American Association of Equine Practitioners recommends vaccinating at-risk horses against EIV every six months.9 At-risk horses include those that are less than 6 years of age, geriatric horses and horses that may be frequently exposed to EIV at shows, trail rides or other events.9
Become a horse health expert. Download AQHA’s FREE Potomac Horse Fever report and learn about a specific horse health problem that can affect your horse.
Although disease can be a cause for concern at shows, the guidance from your veterinarian and the right vaccination program can help protect your horse – helping ensure a healthy and successful show season. And, the commitment from Zoetis to providing an immunologically current EIV vaccine has made FLUVAC INNOVATOR the most trusted EIV line of vaccines, as well as the market leader.10
To ensure peace of mind, FLUVAC INNOVATOR vaccines are backed by the Equine Immunization Support Guarantee from Zoetis.† This guarantee provides up to $5,000 for reasonable diagnostic and treatment costs if a horse properly vaccinated by a veterinarian contracts the corresponding equine disease.
For more information on FLUVAC INNOVATOR, contact your veterinarian or visit fluvacinnovator.com. Learn more about other Zoetis equine products at zoetisUS.com.
*Results from this model are based on outcomes and mean summaries from research trials1-3 and include manual inputs of market prices and other variables to customize this report. Results will vary, and printouts generated from this model should not be construed as a guarantee of an outcome.
†This guarantee does not apply to, and Zoetis shall not be liable for, any (x) damages caused as a result of the improper handling, misuse or abuse of the vaccines that are the subject of this guarantee, or the willful misconduct or negligence of any third party, or (y) any indirect, punitive, special, incidental or consequential damages. Zoetis reserves the right to modify or cancel the terms and conditions of this guarantee.
1 Fretz PB, Babiuk LA, McLaughlin B. Equine respiratory disease on the western Canadian racetracks. Can Vet J 1979;20(2):58-61.
2 Manley L, Caceres P. Retrospective cohort study of an equine influenza outbreak in the Chilean army in the metropolitan region of Santiago during 2006, in Proceedings. 12th Symposium of the International Society for Veterinary Epidemiology and Economics, Durban, South Africa 2009:64.
3 Sugita S, Oki H, Hasegawa T, Ishida N. Estimation models for the morbidity of the horses infected with influenza virus. J Equine Sci 2008;19(3):63-66.
4 Data on file, Study Report No. 671-02-001R, Zoetis Inc.
5 Data on file, Study Report No. 671-08-004.R, Zoetis Inc.
6 Data on file, Study Report No. 766-09-002.R, Zoetis Inc.
7 Data on file, Study Report No. 10OREQBIO-01, Zoetis Inc.
8 Data on file, Study Report No. 14OREQBIO-1, Zoetis Inc.
9 American Association of Equine Practitioners. Equine Influenza. Available at: http://www.aaep.org/-i-175.html. Accessed August 4, 2014.
10 Data on file, MDI Sales Data from 2004-2013, Zoetis Inc.
All trademarks are the property of Zoetis Inc., its affiliates and/or its licensors. ©2014 Zoetis Inc. All rights reserved. FLU-00034